Resolution of dyskinesia and the "on-off" phenomenon in thyrotoxic patients with Parkinson's disease after antithyroid treatment.
- 5 July 1986
- Vol. 293 (6538) , 38-39
- https://doi.org/10.1136/bmj.293.6538.38
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- DOES ESTROGEN REPLACEMENT THERAPY PREDISPOSE TO THROMBOSIS?Acta Obstetricia et Gynecologica Scandinavica, 1985
- COMPARISON OF LIPID AND ANDROGEN LEVELS AFTER CONJUGATED ESTROGEN OR DEPO-MEDROXYPROGESTERONE ACETATE TREATMENT IN POSTMENOPAUSAL WOMEN1985
- Comparison between degree of systemic absorption of vaginally and orally administered estrogens at different dose levels in postmenopausal womenAmerican Journal of Obstetrics and Gynecology, 1981
- Use of Thyrotropin-Releasing Hormone In Clinical MedicineMedical Clinics of North America, 1978
- "ON-OFF" EFFECTS IN PATIENTS WITH PARKINSON'S DISEASE ON CHRONIC LEVODOPA THERAPYThe Lancet, 1976
- Interaction of Thyrotropin-Releasing Hormone and Dopamine on the Release of Prolactin from the Rat Anterior Pituitaryin Vitro1Endocrinology, 1974
- HYPERTHYROIDISM IN PATIENTS OVER THE AGE OF 60 YEARSMedicine, 1974
- Parkinsonism and HyperthyroidismEuropean Neurology, 1974
- BRIEF ASSESSMENT OF THE MENTAL STATE IN GERIATRIC DOMICILIARY PRACTICE. THE USEFULNESS OF THE MENTAL STATUS QUESTIONNAIREAge and Ageing, 1973
- L-DOPA SUPPRESSION OF THYROTROPIN RELEASING HORMONE RESPONSE IN MAN1Journal of Clinical Endocrinology & Metabolism, 1972